Moderna (MRNA) is a leading biotechnology business based in the US. It opened the day at $0.00 after a previous close of $122.50. During the day the price has varied from a low of $0.00 to a high of $0.00. The latest price was $122.30 (25 minute delay). Moderna is listed on the NASDAQ and employs 5,600 staff. All prices are listed in US Dollars.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Open | $0.00 |
|---|---|
| High | $0.00 |
| Low | $0.00 |
| Close | $122.30 |
| Previous close | $122.50 |
| Change | $-0.20 |
| Change % | -0.1618% |
| Volume | 2,424 |
| 52-week range | $62.55 - $170.47 |
|---|---|
| 50-day moving average | $135.37 |
| 200-day moving average | $105.18 |
| Wall St. target price | $145.20 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-15.60 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $122.3018 from 2024-07-22
| 1 week (2024-07-16) | -2.27% |
|---|---|
| 1 month (2024-06-21) | -8.32% |
| 3 months (2024-04-23) | 13.36% |
| 6 months (2024-01-23) | 20.00% |
| 1 year (2023-07-21) | -3.27% |
|---|---|
| 2 years (2022-07-22) | -25.21% |
| 3 years (2021-07-23) | 348.83 |
| 5 years (2019-07-23) | 799.28% |
| Revenue TTM | $5.2 billion |
|---|---|
| Gross profit TTM | $10.6 billion |
| Return on assets TTM | -15.72% |
| Return on equity TTM | -37.68% |
| Profit margin | -115.82% |
| Book value | $33.47 |
| Market Capitalization | $46.5 billion |
TTM: trailing 12 months
We're not expecting Moderna to pay a dividend over the next 12 months.
Over the last 12 months, Moderna's shares have ranged in value from as little as $62.55 up to $170.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 1.662. This would suggest that Moderna's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co. , Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S. p.
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.